UNS unilife corporation

I'm a bit cautious on Sanofi. They seem to be slow adopters...

  1. 13,958 Posts.
    lightbulb Created with Sketch. 139
    I'm a bit cautious on Sanofi. They seem to be slow adopters compared to Amgen and Medimmune. The break up of our revenue stands testimony to that, most of our revenue comes from two customers with a few hundred thousand from the third (I'm thinking that being Sanofi). I'm actually hesitant now in believing the auto-injector for Duplipumab is a WI... just seems a bit too early for me... if it was the other two customers, for sure....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.